E3	Condition:T3 Name:T4
E6	Condition:T6 Name:T7
E8	Condition:T8 Name:T9
E12	Condition:T12 Name:T13
E14	Condition:T14 Name:T15
E15	Eq-Comparison:T22 Operator:T16 Value:T19 Unit:T34 Per:T35
E16	Eq-Comparison:T23 Operator:T17 Temporal-Unit:T18 Value:T20
E1	Condition:T1 Severity:T2
E2	And:T10 Arg:T5 Arg2:E1
E4	Assertion:T11 Asserted:E3
E5	And:T24 Arg:E1 Arg2:E3
E7	Or:T25 Arg:E8 Arg2:E6
E9	Allergy:T26 Name:E10
E10	Drug:T27 Name:T28
E11	Drug:T29 Name:T30
E13	Or:T31 Arg:E10 Arg2:E11
E17	Observation:T32 Name:T33 Eq-Comparison:E15
E18	Drug:T36 Name:T37
E19	Drug:T39 Name:T38
E20	Drug:T40 Name:T41
E21	Drug:T42 Name:T43
E22	Drug:T44 Name:T45
E23	Or:T46 Arg:E21 Arg2:E22
E24	Assertion:T47 Asserted:E25
E25	Drug:T48 Name:T49 Temporality:E16
E26	Condition:T50 Name:T51
E27	Condition:T52 Name:T53
E28	Condition:T54 Name:T55
E29	Or:T56 Arg:E14 Arg2:E28
E30	Assertion:T57 Asserted:E31
E31	Drug:T58 Temporality:E32
E32	Eq-Comparison:T59 Temporal-Unit:T61 Operator:T60 Value:T21
T3	Condition 80 78	MRSA infection
T4	Condition-Name 80 78	MRSA infection
T5	Life-Stage-And-Gender 33 31	Adults
T6	Condition 151 143	breast feeding
T7	Condition-Name 151 143	breast feeding
T8	Condition 133 125	Pregnancy
T9	Condition-Name 133 125	Pregnancy
T12	Condition 566 517	HIV infection
T13	Condition-Name 566 517	HIV infection
T14	Condition 597 547	systemic lupus erythematoses
T15	Condition-Name 597 547	systemic lupus erythematoses
T16	Eq-Operator 252 236	≥
T17	Eq-Operator 464 426	within
T18	Eq-Temporal-Unit 472 433	days
T19	Eq-Value 255 237	2
T20	Eq-Value 467 428	7
T21	Eq-Value 701 642	72
T22	Eq-Comparison 255 237	≥2
T23	Eq-Comparison 472 433	within 7 days
T1	Condition 56 54	ill
T2	Severity 52 50	critically
T10	And 37 35	who
T11	Assertion 91 89	suspection
T24	And 60 58	and
T25	Or 136 128	or
T26	Allergy 175 163	allergy
T27	Drug 196 184	vancomycin
T28	Drug-Name 196 184	vancomycin
T29	Drug 213 201	ascorbic acid
T30	Drug-Name 213 201	ascorbic acid
T31	Or 199 187	or
T32	Observation 250 234	serum creatinine
T33	Observation-Name 250 234	serum creatinine
T34	Eq-Unit 258 239	mg
T35	Eq-Unit 263 242	dl
T36	Drug 315 290	nephrotoxic drug
T37	Drug-Name 315 290	nephrotoxic drug
T38	Drug-Name 343 313	aminoglycosides
T39	Drug 343 313	aminoglycosides
T40	Drug 360 329	amphotericin B
T41	Drug-Name 360 329	amphotericin B
T42	Drug 372 340	cisplatin
T43	Drug-Name 372 340	cisplatin
T44	Drug 398 366	calcinurine inhibitors
T45	Drug-Name 398 366	calcinurine inhibitors
T46	Or 375 343	or
T47	Assertion 423 385	Anticepated
T48	Drug 457 419	contrast medium
T49	Drug-Name 457 419	contrast medium
T50	Condition 531 488	diseases
T51	Condition-Name 531 488	diseases
T52	Condition 550 502	cancer
T53	Condition-Name 550 502	cancer
T54	Condition 623 571	urinary tract stones
T55	Condition-Name 623 571	urinary tract stones
T56	Or 602 550	or
T57	Assertion 649 591	Unlikelyhood
T58	Drug 684 626	medications
T59	Eq-Comparison 707 648	at least 72 hours
T60	Eq-Operator 697 639	at least
T61	Eq-Temporal-Unit 707 648	hours
A1	Life-Stage-And-Gender-Type T5 adult
A2	Eq-Operator-Value T16 GTEQ
A3	Eq-Operator-Value T17 LTEQ
A4	Eq-Temporal-Unit-Value T18 day
A5	Severity-Value T2 severe
A6	Assertion-Type-Value E4 possible
A7	Observation-Type-Value T33 lab
A8	Assertion-Type-Value E24 hypothetical
A9	Assertion-Type-Value E30 hypothetical
A10	Eq-Operator-Value T60 LTEQ
A11	Eq-Temporal-Unit-Value T61 hour
R1	Example-Of Arg1:E19 Arg2:E18
R2	Example-Of Arg1:E20 Arg2:E18
R3	Example-Of Arg1:E21 Arg2:E18
R4	Example-Of Arg1:E22 Arg2:E18
R5	Example-Of Arg1:E27 Arg2:E26
R6	Example-Of Arg1:E12 Arg2:E26
R7	Example-Of Arg1:E14 Arg2:E26
R8	Example-Of Arg1:E28 Arg2:E26